413 related articles for article (PubMed ID: 29421541)
1. Ion channel dysfunction in cerebellar ataxia.
Bushart DD; Shakkottai VG
Neurosci Lett; 2019 Jan; 688():41-48. PubMed ID: 29421541
[TBL] [Abstract][Full Text] [Related]
2. Discovery of Novel Activators of Large-Conductance Calcium-Activated Potassium Channels for the Treatment of Cerebellar Ataxia.
Srinivasan SR; Huang H; Chang WC; Nasburg JA; Nguyen HM; Strassmaier T; Wulff H; Shakkottai VG
Mol Pharmacol; 2022 Jul; 102(1):438-449. PubMed ID: 35489717
[TBL] [Abstract][Full Text] [Related]
3. Translating cerebellar Purkinje neuron physiology to progress in dominantly inherited ataxia.
Chopra R; Shakkottai VG
Future Neurol; 2014 Mar; 9(2):187-196. PubMed ID: 25221437
[TBL] [Abstract][Full Text] [Related]
4. Kv3.3 channels harbouring a mutation of spinocerebellar ataxia type 13 alter excitability and induce cell death in cultured cerebellar Purkinje cells.
Irie T; Matsuzaki Y; Sekino Y; Hirai H
J Physiol; 2014 Jan; 592(1):229-47. PubMed ID: 24218544
[TBL] [Abstract][Full Text] [Related]
5. Fundamental Mechanisms of Autoantibody-Induced Impairments on Ion Channels and Synapses in Immune-Mediated Cerebellar Ataxias.
Mitoma H; Honnorat J; Yamaguchi K; Manto M
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668612
[TBL] [Abstract][Full Text] [Related]
6. Targeting Ion Channels and Purkinje Neuron Intrinsic Membrane Excitability as a Therapeutic Strategy for Cerebellar Ataxia.
Huang H; Shakkottai VG
Life (Basel); 2023 Jun; 13(6):. PubMed ID: 37374132
[TBL] [Abstract][Full Text] [Related]
7. Physiologic alterations in ataxia: channeling changes into novel therapies.
Shakkottai VG; Paulson HL
Arch Neurol; 2009 Oct; 66(10):1196-201. PubMed ID: 19822774
[TBL] [Abstract][Full Text] [Related]
8. Enhanced neuronal excitability in the absence of neurodegeneration induces cerebellar ataxia.
Shakkottai VG; Chou CH; Oddo S; Sailer CA; Knaus HG; Gutman GA; Barish ME; LaFerla FM; Chandy KG
J Clin Invest; 2004 Feb; 113(4):582-90. PubMed ID: 14966567
[TBL] [Abstract][Full Text] [Related]
9. Altered synaptic and firing properties of cerebellar Purkinje cells in a mouse model of ARSACS.
Ady V; Toscano-Márquez B; Nath M; Chang PK; Hui J; Cook A; Charron F; Larivière R; Brais B; McKinney RA; Watt AJ
J Physiol; 2018 Sep; 596(17):4253-4267. PubMed ID: 29928778
[TBL] [Abstract][Full Text] [Related]
10. A Recurrent Mutation in CACNA1G Alters Cav3.1 T-Type Calcium-Channel Conduction and Causes Autosomal-Dominant Cerebellar Ataxia.
Coutelier M; Blesneac I; Monteil A; Monin ML; Ando K; Mundwiller E; Brusco A; Le Ber I; Anheim M; Castrioto A; Duyckaerts C; Brice A; Durr A; Lory P; Stevanin G
Am J Hum Genet; 2015 Nov; 97(5):726-37. PubMed ID: 26456284
[TBL] [Abstract][Full Text] [Related]
11. Vulnerability of Human Cerebellar Neurons to Degeneration in Ataxia-Causing Channelopathies.
Bushart DD; Shakkottai VG
Front Syst Neurosci; 2022; 16():908569. PubMed ID: 35757096
[TBL] [Abstract][Full Text] [Related]
12. Disrupted Calcium Signaling in Animal Models of Human Spinocerebellar Ataxia (SCA).
Prestori F; Moccia F; D'Angelo E
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31892274
[TBL] [Abstract][Full Text] [Related]
13. Dendritic potassium channel dysfunction may contribute to dendrite degeneration in spinocerebellar ataxia type 1.
Chopra R; Bushart DD; Shakkottai VG
PLoS One; 2018; 13(5):e0198040. PubMed ID: 29847609
[TBL] [Abstract][Full Text] [Related]
14. Introducing treatment strategy for cerebellar ataxia in mutant med mice: combination of acetazolamide and 4-aminopyridine.
Abbasi S; Abbasi A; Sarbaz Y
Comput Methods Programs Biomed; 2014 Feb; 113(2):697-704. PubMed ID: 24326337
[TBL] [Abstract][Full Text] [Related]
15. Infant and adult SCA13 mutations differentially affect Purkinje cell excitability, maturation, and viability in vivo.
Hsieh JY; Ulrich BN; Issa FA; Lin MA; Brown B; Papazian DM
Elife; 2020 Jul; 9():. PubMed ID: 32644043
[TBL] [Abstract][Full Text] [Related]
16. A point mutation in TRPC3 causes abnormal Purkinje cell development and cerebellar ataxia in moonwalker mice.
Becker EB; Oliver PL; Glitsch MD; Banks GT; Achilli F; Hardy A; Nolan PM; Fisher EM; Davies KE
Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6706-11. PubMed ID: 19351902
[TBL] [Abstract][Full Text] [Related]
17. Cerebellar ataxias: β-III spectrin's interactions suggest common pathogenic pathways.
Perkins E; Suminaite D; Jackson M
J Physiol; 2016 Aug; 594(16):4661-76. PubMed ID: 26821241
[TBL] [Abstract][Full Text] [Related]
18. Redefining cerebellar ataxia in degenerative ataxias: lessons from recent research on cerebellar systems.
Tada M; Nishizawa M; Onodera O
J Neurol Neurosurg Psychiatry; 2015 Aug; 86(8):922-8. PubMed ID: 25637456
[TBL] [Abstract][Full Text] [Related]
19. Transient cerebellar alterations during development prior to obvious motor phenotype in a mouse model of spinocerebellar ataxia type 6.
Jayabal S; Ljungberg L; Watt AJ
J Physiol; 2017 Feb; 595(3):949-966. PubMed ID: 27531396
[TBL] [Abstract][Full Text] [Related]
20. De novo mutation screening in childhood-onset cerebellar atrophy identifies gain-of-function mutations in the CACNA1G calcium channel gene.
Chemin J; Siquier-Pernet K; Nicouleau M; Barcia G; Ahmad A; Medina-Cano D; Hanein S; Altin N; Hubert L; Bole-Feysot C; Fourage C; Nitschké P; Thevenon J; Rio M; Blanc P; Vidal C; Bahi-Buisson N; Desguerre I; Munnich A; Lyonnet S; Boddaert N; Fassi E; Shinawi M; Zimmerman H; Amiel J; Faivre L; Colleaux L; Lory P; Cantagrel V
Brain; 2018 Jul; 141(7):1998-2013. PubMed ID: 29878067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
